Literature DB >> 9510470

Infrequent mutations in the PTEN/MMAC1 gene among primary breast cancers.

K Ueda1, M Nishijima, H Inui, M Watatani, E Yayoi, J Okamura, M Yasutomi, Y Nakamura, Y Miyoshi.   

Abstract

Recently PTEN/MMAC1, a candidate tumor suppressor gene, was isolated from chromosome 10q23-24 and somatic mutations of this gene were detected in several malignancies including brain, prostate, and breast tumors. To investigate further the potential role of this gene in mammary carcinogenesis, we examined 69 primary breast cancers for mutations in PTEN/MMAC1 by means of polymerase chain reaction single-strand conformation polymorphism and sequencing analysis. We detected only one somatic missense mutation, a change from T to C at codon 59 (TCA to CCA) resulting in substitution of Pro for Ser in the predicted protein. This site is located outside of phosphatase or phosphate-acceptor motifs, but this codon encodes a residue that is conserved in homologous proteins, tensin and auxilin and is likely to be crucial for normal function of PTEN/MMAC1. Among the 69 tumors examined, three low-frequency polymorphisms were found as well, one in the non-coding region of exon 1 and one each in introns 2 and 7. Our results suggested that mutation of the PTEN/MMAC1 gene is not a major factor in the development of most primary breast cancers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9510470      PMCID: PMC5921581          DOI: 10.1111/j.1349-7006.1998.tb00473.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


loss of heterozygosity phosphatase and tensin homolog deleted on chromosome ten mutated in multiple advanced cancers 1 polymerase chain reaction single‐strand conformation polymorphism
  14 in total

1.  Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease.

Authors:  M R Nelen; W C van Staveren; E A Peeters; M B Hassel; R J Gorlin; H Hamm; C F Lindboe; J P Fryns; R H Sijmons; D G Woods; E C Mariman; G W Padberg; H Kremer
Journal:  Hum Mol Genet       Date:  1997-08       Impact factor: 6.150

2.  Specific chromosomal abnormalities in malignant human gliomas.

Authors:  S H Bigner; J Mark; P C Burger; M S Mahaley; D E Bullard; L H Muhlbaier; D D Bigner
Journal:  Cancer Res       Date:  1988-01-15       Impact factor: 12.701

3.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.

Authors:  D Liaw; D J Marsh; J Li; P L Dahia; S I Wang; Z Zheng; S Bose; K M Call; H C Tsou; M Peacocke; C Eng; R Parsons
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

4.  Microsatellite instability and loss of heterozygosity in primary breast tumours.

Authors:  G Sourvinos; H Kiaris; A Tsikkinis; S Vassilaros; D A Spandidos
Journal:  Tumour Biol       Date:  1997

5.  Allelic loss detected on chromosomes 8, 10, and 17 by fluorescence in situ hybridization using single-copy P1 probes on isolated nuclei from paraffin-embedded prostate tumors.

Authors:  D A Deubler; B J Williams; X L Zhu; M R Steele; L R Rohr; J C Jensen; R A Stephenson; J E Changus; G J Miller; M J Becich; A R Brothman
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

6.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.

Authors:  P A Steck; M A Pershouse; S A Jasser; W K Yung; H Lin; A H Ligon; L A Langford; M L Baumgard; T Hattier; T Davis; C Frye; R Hu; B Swedlund; D H Teng; S V Tavtigian
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

7.  PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.

Authors:  J Li; C Yen; D Liaw; K Podsypanina; S Bose; S I Wang; J Puc; C Miliaresis; L Rodgers; R McCombie; S H Bigner; B C Giovanella; M Ittmann; B Tycko; H Hibshoosh; M H Wigler; R Parsons
Journal:  Science       Date:  1997-03-28       Impact factor: 47.728

8.  Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.

Authors:  T Sato; A Tanigami; K Yamakawa; F Akiyama; F Kasumi; G Sakamoto; Y Nakamura
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

9.  Alterations of the TP53 gene in human gliomas.

Authors:  B K Rasheed; R E McLendon; J E Herndon; H S Friedman; A H Friedman; D D Bigner; S H Bigner
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

10.  Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.

Authors:  M M Ittmann
Journal:  Prostate       Date:  1996-05       Impact factor: 4.104

View more
  10 in total

Review 1.  Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

Authors:  M M de Jong; I M Nolte; G J te Meerman; W T A van der Graaf; J C Oosterwijk; J H Kleibeuker; M Schaapveld; E G E de Vries
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

Review 2.  New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway.

Authors:  L C Cantley; B G Neel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

3.  PTEN mutations in malignant gliomas and their relation with meningeal gliomatosis.

Authors:  S Izumoto; T Ohnishi; H Kanemura; N Arita; M Maruno; T Moriuchi; S Suzuki; T Yoshimine
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

4.  Negative Regulation of Receptor Tyrosine Kinase (RTK) Signaling: A Developing Field.

Authors:  Fernanda Ledda; Gustavo Paratcha
Journal:  Biomark Insights       Date:  2007-02-14

5.  Germline PTEN mutations in Cowden syndrome-like families.

Authors:  D J Marsh; P L Dahia; S Caron; J B Kum; I M Frayling; I P Tomlinson; K S Hughes; R A Eeles; S V Hodgson; V A Murday; R Houlston; C Eng
Journal:  J Med Genet       Date:  1998-11       Impact factor: 6.318

6.  Characterization of a novel PTEN mutation in MDA-MB-453 breast carcinoma cell line.

Authors:  Gobind Singh; Leticia Odriozola; Hong Guan; Colin R Kennedy; Andrew M Chan
Journal:  BMC Cancer       Date:  2011-11-21       Impact factor: 4.430

7.  Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.

Authors:  Francine Durocher; Yvan Labrie; Penny Soucy; Olga Sinilnikova; Damian Labuda; Paul Bessette; Jocelyne Chiquette; Rachel Laframboise; Jean Lépine; Bernard Lespérance; Geneviève Ouellette; Roxane Pichette; Marie Plante; Sean V Tavtigian; Jacques Simard
Journal:  BMC Cancer       Date:  2006-09-29       Impact factor: 4.430

Review 8.  PTEN deficiency: a role in mammary carcinogenesis.

Authors:  T Petrocelli; J M Slingerland
Journal:  Breast Cancer Res       Date:  2001-10-01       Impact factor: 6.466

9.  Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.

Authors:  D Freihoff; A Kempe; B Beste; B Wappenschmidt; E Kreyer; Y Hayashi; A Meindl; D Krebs; O D Wiestler; A von Deimling; R K Schmutzler
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

10.  Somatic mutations of the PTEN/MMAC1 gene in fifteen Japanese endometrial cancers: evidence for inactivation of both alleles.

Authors:  K Kurose; K Bando; K Fukino; Y Sugisaki; T Araki; M Emi
Journal:  Jpn J Cancer Res       Date:  1998-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.